Navigation Links
Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
Date:12/16/2010

ANN ARBOR, Mich., Dec. 16, 2010 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it has acquired access to clinical data supporting a zinc-based therapy for the prevention of infections in the elderly. This acquisition expands and enhances Adeona's zinc-based product candidate portfolio that already includes its proprietary zinc-based tablets for use in the dietary management of mild to moderate Alzheimer's disease and mild cognitive impairment patients, and age-related macular degeneration. In addition, Adeona also announced the appointment of the zinc research pioneer, Ananda S. Prasad, M.D., Ph.D., to the Company's Scientific Advisory Board.

"I am pleased to join the Scientific Advisory Board of Adeona, a company leading the development of zinc-based therapies addressing diseases in the elderly," said Ananda S. Prasad, M.D., Ph.D. "I look forward to providing guidance as Adeona moves their promising zinc-based product candidates through development."

Zinc for Prevention of Infection in the Elderly

Adeona has entered into an agreement with Dr. Prasad that provides the Company with access to clinical data from a 50 patient, 12-month, randomized, double-blind, placebo-controlled clinical trial that evaluated the prevention of infection in patients age 55 to 87 who were treated with an oral zinc therapy (45 mg elemental zinc per day away from food) or matching placebo. The clinical trial was conducted by Dr. Prasad and co-investigators. The primary endpoint of the clinical trial was the rate of infections between the placebo and zinc treated groups. The results at 12 months demonstrated a 67% reduction in the incidence of infection between the two groups (88 infections in the placebo group versus 29 infections in the zinc trea
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Adeona Announces Third Quarter 2010 Financial Results and Achievements
2. Adeona to Hold Annual Shareholder Meeting
3. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
4. Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimers Disease and Cognitive Decline
5. Adeona Announces Second Quarter 2010 Profitability and Achievements
6. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
7. Adeona Announces HartLab Expansion Into Microbiology Testing Services
8. Medicalis Acquires RadWorkFlow from Inland Imaging and Providence Health Care
9. Cambrex Acquires Stake in Zenara Pharma
10. RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs
11. Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 PositiveID Corp. (OTCQB: PSID), ... , is an emerging player in the bio-threat ... bio-threat detection and rapid medical testing. The Company,s ... Bio-agent Autonomous Networked Detector), was developed under contract ... Science & Technology directorate, and $30 million of ...
(Date:7/23/2014)... PLYMOUTH MEETING, Pa. , July 23, ... MKT: INO) today announced successful results from ... of VGX-3100 in women with biopsy-proven cervical ... papillomavirus (HPV) types 16 or 18. Treatment ... histopathological regression of CIN2/3 to CIN1 or ...
(Date:7/23/2014)... , July 23, 2014  Nearly 8,000 attendees ... for Cardinal Health,s annual Retail Business Conference (RBC), taking ... Convention Center. This year,s event encourages pharmacists to "Lead ... their communities and for their future. ... owners to network with their peers and learn new ...
Breaking Medicine Technology:PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6
... BIRMINGHAM, Ala., March 10, 2011 PNP ... from research conducted at Southern Research Institute and The ... that several major objectives have been reached in the ... for the treatment of cancer. "A number ...
... InstaCare Corp. (OTC Bulletin Board: ISCR ), ... the chronically ill, a leading fulfillment provider of direct to ... pending cell phone centric e -health products and technologies, ... pharmaceutical e-detailing Mobile Health Media System, known as ...
Cached Medicine Technology:PNP Therapeutics Meets Important Financial and Regulatory Objectives in Development of New Cancer Therapies 2InstaCare Announces Ready for Market MD@Detail Mobile Health Media System for Pharmaceutical e-Detailing 2InstaCare Announces Ready for Market MD@Detail Mobile Health Media System for Pharmaceutical e-Detailing 3
(Date:7/23/2014)... body of research suggesting a safe and effective ... breast cancer, with fewer detrimental side effects and ... The study will be published in final format ... and Endocrinology . , Breast cancer is the ... United States. Approximately 70% of breast cancers are ...
(Date:7/23/2014)... Rich Dad® Education, a leader in financial education, ... sale to support Habit for Humanity of Lee and Hendry ... will be donated to Habitat for Humanity. Additionally, all the ... the Habitat for Humanity ReStore thrift store located at 31 ... of the highlights of the yard sale was a visit ...
(Date:7/23/2014)... York, New York (PRWEB) July 23, 2014 ... ) continue to move forward in a federal multidistrict ... Texas, Bernstein Liebhard LLP reports. According to an Order ... denied a hospital’s bid for payment of a $1,000 ... explanted hip implant. , Among other things, the ...
(Date:7/23/2014)... disorders of obesity and dementia reside in the brain, ... Behavioral Neuroscience. In the paper, researchers make the case ... the brain responsible for memory and learning. Furthermore, treatments ... in reducing certain dementias., "In the struggle to treat ... This is a new way for providers who treat ...
(Date:7/23/2014)... 23, 2014 Olympic gold medal-winning speed ... Virginia on Friday, July 18. Hedrick visited Roanoke as ... Commonwealth Games, an Olympic-style event celebrating its 25th Anniversary ... as a premier sponsor of the Commonwealth Games, which ... all ages and all activity levels. , Hedrick, a ...
Breaking Medicine News(10 mins):Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Hip Lawsuits Move Forward, as Federal Judge Denies Hospital Bid for $1000 Explant Fee, Bernstein Liebhard LLP Reports 4Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:US Olympian Chad Hedrick Visits Foot Levelers 2
... and what can be done to activate the cells to ... to kill // cancer may be due to different cell ... they have found a method to activate the anti-cancer cells ... breast cancer patients and separated the anti-cancer cells. The cells ...
... of nuts or peanut butter can significantly cut your risk ... study.// Consuming a one-ounce serving of peanuts or other nuts ... of cholecystectomy, or removal of the gallbladder, by 25 percent. ... more times a week lowers the risk by 15 percent. ...
... Johns wort is a popular herb taken by many ... with certain drugs and that it can be dangerous,// ... 22 research trials that examined drug interactions with St. ... Researchers reviewed how the studies were conducted and the ...
... a woman is diagnosed with cancer, she often has to ... to stop functioning // and leave the patient infertile. But ... remove, freeze and restore a woman’s ovarian tissue. ,New ... to be very promising for women being treated for cancer. ...
... that heart attacks don't just strike overweight adults. Overweight ... from // The Cincinnati Children's Hospital Medical Center in ... thickness of the left ventricle, which is responsible for ... of having a heart attack, no matter the age ...
... a woman to get pregnant, say researchers based on finding ... study researchers looked at how the maternal diet prior to ... of the fetus. They found that a diet consisting of ... embryos at an early stage in their development. Some mice ...
Cached Medicine News:
Thermal Cautery, Sterile Single-Use Units for Vasectomy. Burns at approximately 1200C (2200 F). Integrated unit includes handle, vasectomy tip, & AA batteries. Box of 10 units. Discounts on 2 or more...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
... users of "completely-in-the-canal" (CIC) instruments of ... ,Impressions of your ears are required. ... the ear are distributed via our ... These providers include audiologists and hearing ...
... bronchoscopy: The HF-compatible V series from Pentax, ... bronchoscopes are measured., ,The HF-compatible series ... FB-19TV, FB-18V and FB-15V models along with ... FB-8V, offer much better image quality thanks ...
Medicine Products: